4
Changes in Ownership
CYTOKINETICS INC Filed Acc 0001127602-25-001059
EVP Research & Development sold 2,000 shares at $49.32 ($98,640)
- EVP Research & Development acquired 2,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Malik Fady Ibraham EVP Research & Development | 2025-01-07 | Option exercise 10b5-1 | +2,000 | $10.60 | $21,200 | 118,071 | D |
| Malik Fady Ibraham EVP Research & Development | 2025-01-07 | Sale 10b5-1 | −2,000 | $49.32 | $98,640 | 116,071 | D |
| Derivatives | |||||||
| Malik Fady Ibraham EVP Research & Development | 2025-01-07 | Option exercise · Non-Qualified Stock Option (Right to Buy) 10b5-1 | −2,000 | 39,105 | D | ||
| Open-market sales · 2,000 sh · avg $49.32 · $98,640 | |||||||
Loading xslF345X05/form4.xml…